logo

Andrea Kovacs, MD

Andrea Kovacs, MD

Pediatric Infectious Disease Los Angeles, CA

Professor, Pediatrics, USC School of Medicine

Office Address

Office Map
  • 4650 W Sunset Blvd
    Ms#51
    Los Angeles, CA 90027
    Phone: (323) 226-5068
    Fax: (323) 226-8362

Summary

  • Dr. Andrea Kovacs, MD is a board certified pediatric infectious disease specialist in Los Angeles, California. She is currently licensed to practice medicine in California. She is affiliated with Los Angeles County-USC Medical Center and Huntington Memorial Hospital.

Dr. Kovacs's Clinical Specialties & Interests

  • Pediatric Infectious Disease: General Pediatric Infectious Disease

Dr. Kovacs's Education & Medical Training

  • University of Southern California/LAC+USC Medical CenterUniversity of Southern California/LAC+USC Medical CenterResidency, Pediatrics
  • New York Med CollNew York Medical CollegeMedical School

Dr. Kovacs's Certifications & Licensure

  • CA State Medical LicenseCA State Medical LicenseActive through 2013
  • American Board of PediatricsAmerican Board of PediatricsPediatrics
  • American Board of PediatricsAmerican Board of PediatricsPediatric Infectious Diseases

Dr. Kovacs's Awards, Honors, & Recognition

  • American Academy of PediatricsFellow (FAAP)American Academy of Pediatrics
  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Kovacs's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • HCV And HIV Progression In Women On Haart
    HCV And HIV Progression In Women On HaartNational Institute Of Allergy And Infectious Diseases
    2008 - 2011
  • An Open-Label Study Of A Once Daily Dose Of Emtricitabine In Combination With
    An Open-Label Study Of A Once Daily Dose Of Emtricitabine In Combination WithNational Center For Research Resources
    2005 - 2006
  • Prevalence Of Morphologic And Metabolic Abnormalities In HIV Infected
    Prevalence Of Morphologic And Metabolic Abnormalities In HIV InfectedNational Center For Research Resources
    2005 - 2005
  • Open-Label Study Of A Once Daily Dose Of Emtricitabine
    Open-Label Study Of A Once Daily Dose Of EmtricitabineNational Center For Research Resources
    2004 - 2004
  • Phase I/II Trial Of Subcutaneous IL-2 With Haart
    Phase I/II Trial Of Subcutaneous IL-2 With HaartNational Center For Research Resources
    2004 - 2004
  • ACTG 265:  A Phase I/II Study Of Safety &Immunogenicity Of Live-Attenuated
    ACTG 265: A Phase I/II Study Of Safety &Immunogenicity Of Live-AttenuatedNational Center For Research Resources
    2004 - 2005
  • HCV And Progression Of HIV And Haart Response In Women
    HCV And Progression Of HIV And Haart Response In WomenNational Institute Of Allergy And Infectious Diseases
    2002 - 2005
  • Intron A /Ribavirin In Pediatric PTS W Chronic Hepatitis
    Intron A /Ribavirin In Pediatric PTS W Chronic HepatitisNational Center For Research Resources
    2000 - 2000
  • Zidovudine In Premature Infants Exposed To HIV
    Zidovudine In Premature Infants Exposed To HIVNational Center For Research Resources
    2000 - 2000
  • ACTG 382: DMP 266 (EFAVIRENZ) And Nelfinavir In Children
    ACTG 382: DMP 266 (EFAVIRENZ) And Nelfinavir In ChildrenNational Center For Research Resources
    2000 - 2000
  • ACTG 366: Rad-1 Antiretroviral Management Algorithm
    ACTG 366: Rad-1 Antiretroviral Management AlgorithmNational Center For Research Resources
    2000 - 2000
  • ACTG 377:  4 Antiretroviral Regimens W Protease Inhibitors, Nrtis And Nnrti
    ACTG 377: 4 Antiretroviral Regimens W Protease Inhibitors, Nrtis And NnrtiNational Center For Research Resources
    2000 - 2000
  • Increased Caloric Density Infant Formula On Growth &Nutrition
    Increased Caloric Density Infant Formula On Growth &NutritionNational Center For Research Resources
    1999 - 2002
  • Rolling Arm Master Protocol (PRAM) Of Novel Antiretroviral
    Rolling Arm Master Protocol (PRAM) Of Novel AntiretroviralNational Center For Research Resources
    1999 - 2002
  • 1592U89 W/ Standard Zvd Therapy In Neonates Born To HIV Women
    1592U89 W/ Standard Zvd Therapy In Neonates Born To HIV WomenNational Center For Research Resources
    1999 - 2002
  • Safety And Immunogenicity Of A Seven Valent Pneumococcal Vaccine
    Safety And Immunogenicity Of A Seven Valent Pneumococcal VaccineNational Center For Research Resources
    1998 - 1999
  • Study Of Combined Zidovudine-Lamivudine VS DDI Monotherapy VS Zidovudine
    Study Of Combined Zidovudine-Lamivudine VS DDI Monotherapy VS ZidovudineNational Center For Research Resources
    1998 - 1999
  • Trial Of 2 Doses Of 2', 3'Dideoxyinosine (DDI) In Children Unresponsive To AZT
    Trial Of 2 Doses Of 2', 3'Dideoxyinosine (DDI) In Children Unresponsive To AZTNational Center For Research Resources
    1998 - 1999
  • Phase III Trial Of Oral Isotretinoin VS Observation In Cervical Dysplasia
    Phase III Trial Of Oral Isotretinoin VS Observation In Cervical DysplasiaNational Center For Research Resources
    1998 - 1999
  • Micronized Atovaquone And Azithromycin (At/Az) As Compared To (Tmp/Smx)
    Micronized Atovaquone And Azithromycin (At/Az) As Compared To (Tmp/Smx)National Center For Research Resources
    1998 - 2002
  • A "Pre-Enrollment" Protocol For HIV Infected Adolescents
    A "Pre-Enrollment" Protocol For HIV Infected AdolescentsNational Center For Research Resources
    1998 - 1999
  • Phase I/II Evaluation Of Zidovudine VS Zidovudine And Didanosine On CD4
    Phase I/II Evaluation Of Zidovudine VS Zidovudine And Didanosine On CD4National Center For Research Resources
    1998 - 1999
  • Combination Antiretrovial Therapy In Children And Adolescents With Advanced HIV
    Combination Antiretrovial Therapy In Children And Adolescents With Advanced HIVNational Center For Research Resources
    1998 - 1999
  • Phase II Seroconversion Of Single Dose And Two Dose Measles Vaccination
    Phase II Seroconversion Of Single Dose And Two Dose Measles VaccinationNational Center For Research Resources
    1998 - 2002
  • Follow UP Of Women Participating In ACTG 076
    Follow UP Of Women Participating In ACTG 076National Center For Research Resources
    1998 - 1999
  • Comparison Of Oral Dapsone For Prophylaxis Of Pneumocystis Carinii
    Comparison Of Oral Dapsone For Prophylaxis Of Pneumocystis CariniiNational Center For Research Resources
    1998 - 1999
  • Pharmacokinetic And Tolerence Of Oral Ganciclovir In HIV Infected Children
    Pharmacokinetic And Tolerence Of Oral Ganciclovir In HIV Infected ChildrenNational Center For Research Resources
    1998 - 1999
  • Phase III Evaluation Of Suppressive Therapy For Recurrent Skin Vesicles
    Phase III Evaluation Of Suppressive Therapy For Recurrent Skin VesiclesNational Center For Research Resources
    1997 - 1999
  • Phase III Study Of Hiv-Ig For Prevention Of Maternal Fetal HIV Transmission
    Phase III Study Of Hiv-Ig For Prevention Of Maternal Fetal HIV TransmissionNational Center For Research Resources
    1997 - 1999
  • Pediatric Pulmonary Complications Of Vertically Transmitted HIV Infection
    Pediatric Pulmonary Complications Of Vertically Transmitted HIV InfectionNational Center For Research Resources
    1997 - 1999
  • Zidovudine Versus 2,3-Dideoxyinosine Versus AZT PLUS DDI
    Zidovudine Versus 2,3-Dideoxyinosine Versus AZT PLUS DDINational Center For Research Resources
    1996 - 1999
  • Pediatric LATE Outcome Protocol
    Pediatric LATE Outcome ProtocolNational Center For Research Resources
    1996 - 2002
  • Human Cytomegalovirus, Monokines, And Maternal Transmission Of HIV
    Human Cytomegalovirus, Monokines, And Maternal Transmission Of HIVNational Center For Research Resources
    1996 - 2002
  • Pediatric/Maternal HIV Associated Dementia And Role Of Herpes Virus
    Pediatric/Maternal HIV Associated Dementia And Role Of Herpes VirusNational Center For Research Resources
    1996 - 2002
  • Trial To Evaluate The Safety Of AZT In Pregnant HIV Infected Women
    Trial To Evaluate The Safety Of AZT In Pregnant HIV Infected WomenNational Center For Research Resources
    1996 - 1999
  • Study Of Zidovudine And 2,3-Dideoxyinosine In Children With HIV
    Study Of Zidovudine And 2,3-Dideoxyinosine In Children With HIVNational Center For Research Resources
    1996 - 1999
  • Evaluation Of Treatment Of HIV With Dideoxycytidine
    Evaluation Of Treatment Of HIV With DideoxycytidineNational Center For Research Resources
    1996 - 1999
  • Pulmonary Complications Of Vertically Transmitted HIV Infection
    Pulmonary Complications Of Vertically Transmitted HIV InfectionNational Center For Research Resources
    1996 - 1996
  • Maternal HIV Trans In Pregnant Women &Newborns Receiving AZT
    Maternal HIV Trans In Pregnant Women &Newborns Receiving AZTNational Center For Research Resources
    1996 - 1996
  • High VS Low Dose Zidovudine Administered To Children W/ HIV Infection
    High VS Low Dose Zidovudine Administered To Children W/ HIV InfectionNational Center For Research Resources
    1996 - 1996

Dr. Kovacs's Professional Memberships

  • FellowAmerican Academy of Pediatrics - AAPFellow

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • BCBS Blue Card PPO
  • BCBS California PPO
  • Blue Shield California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO

Alternate Names

  • Dr. Andrea Kovacs, Dr. Andrea Kovacs, MD, Dr. A Kovacs, Dr. Andrea A Kovacs

24 Colleague Invites!
Is this you? If so, register to see 24 messages.

Physicians, view Dr. Kovacs's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV